silodosin

Known as: 1-(3-hydroxypropyl)-5-(2-(2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethylamino)propyl)indoline-7-carboxamide 
An orally available, alpha-1 adrenoreceptor (alpha-1a) selective antagonist that can be used to relieve symptoms of benign prostate hyperplasia (BPH… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
BACKGROUND Using a selective α-blocker for medical expulsive therapy (MET) is a cost-effective treatment approach widely used for… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2014
2014
OBJECTIVES To compare the efficacy and safety of tamsulosin and silodosin in the context of medical expulsive therapy (MET) of… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2011
2011
UNLABELLED What's known on the subject? and What does the study add? Silodosin administered by 4 mg twice daily is as effective… (More)
  • figure 1
  • table 1
  • table 2
  • figure 3
  • figure 2
Is this relevant?
Review
2010
Review
2010
Silodosin is a highly selective alpha1A-adrenoceptor antagonist approved for the treatment of the signs and symptoms of benign… (More)
Is this relevant?
2010
2010
OBJECTIVES To provide clinical evidence that ejaculation disorder caused by selective alpha(1A)-blockers may be associated with… (More)
Is this relevant?
2010
2010
OBJECTIVES To compare the efficacy and safety of silodosin and tamsulosin in patients with lower urinary tract symptoms (LUTS… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
PURPOSE We evaluated the efficacy and safety of silodosin for treatment of benign prostatic hyperplasia symptoms in 2 randomized… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2009
2009
PURPOSE We investigated the effect of the new sympathetic alpha1A-adrenoceptor antagonist silodosin for relieving benign… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
OBJECTIVE To verify the efficacy and safety of the new alpha1A-adrenoceptor-selective antagonist silodosin compared with… (More)
Is this relevant?
2006
2006
The selectivity of silodosin (KMD-3213), an antagonist of alpha(1)-adrenoceptor (AR), to the subtypes (alpha(1A)-, alpha(1B)- and… (More)
Is this relevant?